'Pull' Solutions for Manufacturing
18 MINS READ
The BioSecure Act - Opportunity or mirage?
The BioSecure Act limits U.S. reliance on Chinese biotech, opening doors for Indian CDMOs in biosimilars. This article explores challenges, opportunities, and strategies for India's pharma sector to capitalise on this shift.